The Effect of Bone Mineral Density on Quality of Life in Men with Osteoporosis

Objective: Osteoporosis (OP) is a metabolic bone disease characterized by low bone mass and microarchitectural deterioration of bone tissue. OP is an important health problem with regard to morbidity, mortality, and negative effects on quality of life (QOL). The aim of this study was to evaluate the effect of bone mineral density (BMD) on QOL in men with osteoporosis. Materials and Methods: A total of 180 male patients aged between 40-60 years admitted to Bolu Physical Therapy and Rehabilitation Hospital were included in the study. 113 patients (mean age: 50.01±5.01 years) diagnosed with OP according to BMD values at the lumbar spine (L1-L4) and the femur neck measured using Dual Energy X-Ray absorptiometry were formed the case group, 67 patients (mean age: 44.62±3.86 years) not diagnosed with OP were formed control group. A questionnaire prepared for assessment of sociodemographic features and risk factors for osteoporosis was applied in both groups after they gave their consent. The quality of life was assessed by means of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) and Short Form-36 (SF-36). In the statistical analysis student’s t test and correlation analyses were performed by using SPSS 11.0 computer program and p<0.05 was considered statistically significant. Results: Both femoral neck and lomber spine bone mineral density was lower in the case group than that of the control group (p<0.001). According to QUALEFFO and SF-36 scores, OP was found to reduce the quality of life (p<0.001). Smoking, bone fracture and inadequate daily calcium intake have negative effects on quality of life in the case group (p<0.05). Conclusion: Quality of life was influenced by numerous variables. These results point out that osteoporotic patients should be evaluated multidimensionally and different approaches are needed to improve their quality of life. (Turkish Journal of Osteoporosis 2015;21: 10-4

The Relationship between the Mean Platelet Volume and Subacromial Impingement Syndrome

Objective: Subacromial impingement syndrome (SIS) characterized by inflammation of supraspinatus tendon is one of the most common causes of the shoulder pain. In some studies, platelet activity has been shown as a marker to indicate the inflammation associated with the disease. The mean platelet volume (MPV) shows platelet function and activation. The aim of this study was to investigate the relationship between MPV and SIS. Materials and Methods: Eighty seven inpatients (female/male: 55/32, mean age: 56.34±7.53 years) diagnosed with SIS according to physical examination and MR findings in Bolu Physical Therapy and Rehabilitation Hospital between January 2014- June 2014 constituted the case group, 87 outpatients (female/male 61/26, mean age: 52.97±8.48 years) not diagnosed with SIS constituted the control group. MPV values between case and control group that were similar in terms of age and gender were compared. Results: In case group MPV (8.36±0.73***) was lower than that of the control group (8.44±1.02****) and platelet count (253.75±50.17***) was higher than that of the control group (244.79±56.19***). Both were not statistically significant (p>0.05). Significant negative correlation was found between MPV and platelet level in case group (r=-0.240, p<0.05). Conclusion: These findings present that there is no relationship between MPV and SIS. New prospective studies are needed on this subject. (Turkish Journal of Osteoporosis 2015;21: 15-8

The Evaluation of the Effect of Neuropathic Pain on Functional Disability in Patients with Chronic Low Back Pain

Objective: The aim of this study was to evaluate both the prevalence of neuropathic pain (NP) and the effect of functional disability of NP in patients with chronic low back pain (CLBP). Materials and Methods: In this study, outpatients data were reviewed retrospectively from January 2014 to December 2014 to determine the patients with CLBP. 190 patients with CLBP meeting the inclusion criteria were included. NP scores of the patients were assessed using Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and the evaluation of pain was performed using the Visual analoque scale (VAS) and functional disability scores was determined by the Oswestry disability index (ODI). Results: In this study NP was detected in 39.4% of the patients with CLBP. The number of female patients with NP (n=60, %80) was significantly higher than the number of male patients with NP (n=15, %20), (p<0.05). ODI and VAS scores of the patients with NP [(19.81±7.28), (5.08±0.76)] was significantly higher than those of the patients without NP [(15.28±6.83), (4.44±1.14)], (p<0,001). Conclusion: It was found that the co-existence of NP with CLBP increases pain and functional disability